A year ago, my mother's Alzheimer's disease started to worsen. As a result, I was both concerned and worried.
At the same time, I read a new research study about the combination of Aricept and Namenda as a treatment for Alzheimer's disease.
"The results of this study should change the way we treat patients with Alzheimer's disease. Cholinesterase inhibitors are approved for use in mild to moderate dementia, while memantine has been approved for advanced dementia. But it looks like there is an advantage in prescribing both drugs as initial treatment."--John Growdon, MD
The results of the research study indicated that the combination of Aricept and Namenda helped slow the rate of decline in Alzheimer's patients.
I immediately scheduled an appointment with our doctor to discuss this information.
Our doctor was familiar with the research, and he agree to put my mother on Namenda in a combination with Aricept.
One year later, it is my belief that the combination Aricept and Namenda has slowed the progression of Alzheimer's. We were fortunate, and my mother did not suffer any side effects as the result of the addition of Namenda in her drug regimen.
Subscribe to Living Alzheimer's from the Front Row
